Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Aug 15, 2025; 17(8): 106842
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.106842
Published online Aug 15, 2025. doi: 10.4251/wjgo.v17.i8.106842
Table 3 Inhibitors of lipogenic enzymes involved in gastric cancer
Inhibitor | Target | Comment | Ref. |
Berberine | FABPs | Trigger cell apoptosis by regulating fatty acid metabolism | [57] |
Omeprazole | ACLY | Suppress de novo lipogenesis in gastric epithelial cells | [58] |
Orlistat | FASN | Increase survival from GC | [59] |
A939572 | SCD1 | Disrupts lipid homeostasis | [60] |
Perihexiline | CPT1 | Its combination with oxaliptin suppress progression of GIT cancer | [61] |
Avasimbe | ACAT1 | Target the metabolism of cholesterol of primary gastric tumors | [62] |
- Citation: Amir M, Bakht D, Bokhari SFH, Yousaf R, Iqbal A, Nazir H, Waleed M, Naqvi MZ, Tahir M, Dost W. Lipid metabolism-related genes in gastric cancer: Exploring oncogenic pathways. World J Gastrointest Oncol 2025; 17(8): 106842
- URL: https://www.wjgnet.com/1948-5204/full/v17/i8/106842.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i8.106842